Ipilimumab/nivolumabCardiogenic shock and myocarditis: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1792卷 / 1期

关键词：

D O I：

10.1007/s40278-020-75241-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：133 / 133

相关论文

共 50 条

[31] MinocyclineEosinophilic myocarditis and cardiogenic shock secondary to DRESS syndrome: case report
[J]. Reactions Weekly, 2020, 1821 (1) : 169 - 169
[32] CARDIOGENIC SHOCK SECONDARY TO PEMBROLIZUMAB MYOCARDITIS IN A PATIENT WITH MELANOMA: A CASE REPORT
Suppah, Mustafa
Lam, Travis
Badwal, Areen
Marco, Sean
[J]. CRITICAL CARE MEDICINE, 2024, 52
[33] Early application of extracorporeal membrane oxygenation for myocarditis with shock: a case report
Meng, Heyu
Ruan, Jianjun
Wang, Xue
Shi, Kaiyao
Li, Xiangdong
Liu, Guohui
Meng, Fanbo
Yang, Ping
[J]. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2021, 49 (11)
[34] Ipilimumab/nivolumabLymphocytic myocarditis
[J]. Reactions Weekly, 2024, 2003 (1) : 478 - 478
[35] COVID-19-vaccine/ipilimumab/nivolumabOverlap syndrome of myositis, myasthenia gravis and myocarditis: case report
[J]. Reactions Weekly, 2022, 1917 (1) : 197 - 197
[36] Ipilimumab/nivolumabHepatitis: case report
[J]. Reactions Weekly, 2019, 1734 (1) : 292 - 292
[37] Ipilimumab/nivolumabHypophysitis: case report
[J]. Reactions Weekly, 2022, 1887 (1) : 396 - 396
[38] Ipilimumab/pembrolizumabIleus: case report
[J]. Reactions Weekly, 2023, 1956 (1) : 287 - 287
[39] Ipilimumab/sargramostimDermatomyositis: case report
[J]. Reactions Weekly, 2016, 1603 (1) : 158 - 158
[40] Ipilimumab/nivolumabMyocarditis: case report
[J]. Reactions Weekly, 2021, 1854 (1) : 199 - 199

← 1 2 3 4 5 →